Literature DB >> 12657224

Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol.

G N Theodorakis1, E G Livanis, D Leftheriotis, P Flevari, M Markianos, D Th Kremastinos.   

Abstract

PURPOSE: The aim of the study was to randomly compare clomipramine, used as a challenge-agent during head-up tilt test, with isoproterenol, used in the conventional test, in patients with vasovagal syndrome. SUBJECTS AND METHODS: The serotonergic re-uptake inhibitor clomipramine was infused (5mg in 5min) at the start of head-up tilt test (Clom-HUT) in 126 patients (mean age 41+/-16 years) with positive history of recurrent neurocardiogenic syncope, and in 54 healthy control subjects (mean age 46+/-15 years). All subjects had also been tested with a conventional 60 degrees head-up tilt test (Con-HUT) for 30 min and, if negative, isoproterenol infusion was performed at the end of the test. The two tests were performed in a random order with a 24-h interval between them.
RESULTS: Fifty-two of the 126 patients (41%) and two of the 54 controls had a positive response to Con-HUT. In the Clom-HUT the proportion of patients who experienced a positive response increased to 83% (105 subjects), while this happened only to four control subjects. The predictive accuracy of Clom-HUT increased compared to Con-HUT from 58 to 86%, respectively.
CONCLUSION: The results indicate an increased responsiveness of central serotonergic neural system in subjects with vasovagal syndrome, the activation of which leads to sympathetic withdrawal. The use of clomipramine infusion during tilt test seems to improve considerably its diagnostic value.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657224     DOI: 10.1016/s0195-668x(02)00821-7

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

Review 1.  Vasovagal syncope with asystole: the role of cardiac pacing.

Authors:  Michele Brignole; Marco Tomaino; Alessio Gargaro
Journal:  Clin Auton Res       Date:  2017-07-01       Impact factor: 4.435

2.  Human and monkey prolactin and growth hormone: separation of polymorphic forms by isoelectric focusing.

Authors:  B C Hummel; G M Brown; P Hwang; H G Friesen
Journal:  Endocrinology       Date:  1975-10       Impact factor: 4.736

3.  Management and therapy of vasovagal syncope: A review.

Authors:  Muhammet Ali Aydin; Tushar V Salukhe; Iris Wilke; Stephan Willems
Journal:  World J Cardiol       Date:  2010-10-26

4.  No Impact of Stochastic Galvanic Vestibular Stimulation on Arterial Pressure and Heart Rate Variability in the Elderly Population.

Authors:  Akiyoshi Matsugi; Koji Nagino; Tomoyuki Shiozaki; Yohei Okada; Nobuhiko Mori; Junji Nakamura; Shinya Douchi; Kosuke Oku; Kiyoshi Nagano; Yoshiki Tamaru
Journal:  Front Hum Neurosci       Date:  2021-02-17       Impact factor: 3.169

5.  Cardiovascular safety profile of dapoxetine during the premarketing evaluation.

Authors:  Peter R Kowey; Ramagopal V Mudumbi; Joseph W Aquilina; Peter M DiBattiste
Journal:  Drugs R D       Date:  2011

6.  Tilt table test: state of the art.

Authors:  Gonzalo Barón-Esquivias; Antoni Martínez-Rubio
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01

7.  Small-cell lung cancer with recurrent syncope as the initial symptom: A case report and literature review.

Authors:  Xi Jiang; Jiayi Zhao; Chengguang Bai; Enhong Xu; Zhenhao Chen; Yiping Han
Journal:  Mol Clin Oncol       Date:  2016-09-21

8.  The relationship between clinical characteristics and psychological status and quality of life in patients with vasovagal syncope.

Authors:  Adem Atici; Ramazan Asoglu; Ahmet Demirkiran; Nail Guven Serbest; Baris Emektas; Remzi Sarikaya; Ipek Yeldan; Ahmet Kaya Bilge
Journal:  North Clin Istanb       Date:  2020-02-10

Review 9.  The Search for the Genes of Vasovagal Syncope.

Authors:  Robert S Sheldon; Roopinder K Sandhu
Journal:  Front Cardiovasc Med       Date:  2019-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.